We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunities

    Cytotoxic chemotherapy remains a key modality in cancer treatment. These therapies, successfully used for decades, continue to transform the lives of...

    Article Open access 15 July 2023
  2. Hybrid chitosan gold nanoparticles for photothermal therapy and enhanced cytotoxic action of 6-mercaptopurine on breast cancer cell line

    Background

    One of the most popular anti-inflammatory and anti-leukemic medications is 6-mercaptopurine, along with its riboside derivatives. Because...

    Amna H. Faid, Fatma El Zahraa Hussein, ... Mahmoud A. Sliem in Beni-Suef University Journal of Basic and Applied Sciences
    Article Open access 14 September 2023
  3. Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer

    Breast cancer (BC) has a high mortality rate and is one of the most common malignancies in the world. Initially, BC was considered non-immunogenic,...

    Maryam Jama, Yasser Tabana, Khaled H. Barakat in European Journal of Medical Research
    Article Open access 02 July 2024
  4. Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells

    Immune checkpoint inhibitors (ICIs) have demonstrated efficacy and improved survival in a growing number of cancers. Despite their success, ICIs are...

    Mikel Gurrea-Rubio, Qi Wu, ... David A. Fox in Cancer Immunology, Immunotherapy
    Article Open access 27 January 2024
  5. Examining the effect of activated cytotoxic (CD8+) T-cell exosomes to the lung cancer

    Lung cancer continues to be a major health problem worldwide owing to its incidence, and causes physical, psychological, social, and economic...

    Eldar Sovunjov, Zehra Seda Halbutoğulları, ... Yusufhan Yazır in Medical Oncology
    Article 15 November 2023
  6. Rapid tumor progression complicated with liver abscess in a patient with gastric cancer receiving nivolumab therapy

    Immune checkpoint inhibitors have been approved for treating various cancer types. However, several studies reported rapid tumor progression, a...

    Natsumi Suzuki, Anna Matsuoka, ... Yasuaki Motomura in International Cancer Conference Journal
    Article 01 February 2024
  7. Cytotoxic chemotherapy is associated with decreased bone mineral density in postmenopausal women with early and locally advanced breast cancer

    Purpose

    The burden and mechanisms of endocrine therapy-related bone loss have been studied in detail. However, there is limited data regarding...

    Yadav Nisha, Biswajit Dubashi, ... Prasanth Ganesan in Archives of Osteoporosis
    Article 10 March 2023
  8. Myeloid-derived suppressor cells in cancer and cancer therapy

    Anticancer agents continue to dominate the list of newly approved drugs, approximately half of which are immunotherapies. This trend illustrates the...

    Samantha A. Lasser, Feyza G. Ozbay Kurt, ... Viktor Umansky in Nature Reviews Clinical Oncology
    Article 08 January 2024
  9. Immune checkpoint inhibitor therapy in neoadjuvant and adjuvant treatment for cancer: A paradigm shift in the treatment of resectable gastrointestinal cancer 3)A paradigm shift in the treatment of colorectal cancer

    Immune checkpoint inhibitors, such as anti-programmed cell death-1, programmed cell death ligand-1, and cytotoxic T-lymphocyte antigen-4 monoclonal...

    Kotoe Oshima, Kentaro Yamazaki in International Journal of Clinical Oncology
    Article 05 September 2023
  10. High neutrophil-to-lymphocyte ratio is associated with cancer therapy-related cardiovascular toxicity in high-risk cancer patients under immune checkpoint inhibitor therapy

    Background

    Cancer therapy-related cardiovascular toxicity (CTR-CVT) from immune checkpoint inhibitor (ICI) therapy is still incompletely...

    Elias Haj-Yehia, Raluca I. Mincu, ... Matthias Totzeck in Clinical Research in Cardiology
    Article Open access 13 November 2023
  11. A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure

    Therapy-related myeloid neoplasm (tMN) is considered a direct consequence of DNA damage in hematopoietic stem cells. Despite increasing recognition...

    Monika M. Kutyna, Chung Hoow Kok, ... Devendra K. Hiwase in Leukemia
    Article Open access 29 August 2022
  12. Drug repurposing for cancer therapy

    Cancer, a complex and multifactorial disease, presents a significant challenge to global health. Despite significant advances in surgical,...

    Ying **a, Ming Sun, ... Wei-Lin ** in Signal Transduction and Targeted Therapy
    Article Open access 19 April 2024
  13. Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy

    The standard of treatment for node-positive endometrial cancer (FIGO Stage IIIC) in North America has been systemic therapy with or without...

    Elizabeth A. Tubridy, Neil K. Taunk, Emily M. Ko in Current Treatment Options in Oncology
    Article Open access 04 January 2024
  14. Negative impact on bone homeostasis in postmenopausal women with non-metastatic breast cancer during cytotoxic chemotherapy

    Introduction

    The burden and mechanisms of endocrine therapy-related bone loss are well known, while there are limited data on chemotherapy-induced...

    Yadav Nisha, Biswajit Dubashi, ... Prasanth Ganesan in Journal of Bone and Mineral Metabolism
    Article 06 July 2023
  15. Cancer stem cells: advances in knowledge and implications for cancer therapy

    Cancer stem cells (CSCs), a small subset of cells in tumors that are characterized by self-renewal and continuous proliferation, lead to...

    **an**g Chu, Wentao Tian, ... Rongrong Zhou in Signal Transduction and Targeted Therapy
    Article Open access 05 July 2024
  16. Hair loss during and after breast cancer therapy

    For patients diagnosed with breast cancer, alopecia can be a distressing side effect of treatment. Major surgeries, cytotoxic chemotherapy, and...

    Lucy Rose, Maryam Lustberg, ... Brittany Dulmage in Supportive Care in Cancer
    Article 24 February 2023
  17. Evaluation of the cytotoxic activities of the essential oil from Pistacia atlantica Desf. oleoresin on human gastric cancer cell lines

    Numerous herbal products have been the subject of research regarding their potential role in cancer prevention or adjuvant therapy. Pistacia atlantica ...

    Fatemeh Saeedi, Mohammad Salehi, ... Zahra Memariani in Medical Oncology
    Article 11 May 2024
  18. Estrogen receptor positive breast cancer: contemporary nuances to sequencing therapy

    The treatment landscape of hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer has evolved...

    Jenna Schlefman, Christiana Brenin, ... Patrick Dillon in Medical Oncology
    Article 16 December 2023
  19. In vitro cytotoxic effect of stigmasterol derivatives against breast cancer cells

    Background

    Stigmasterol is an unsaturated phytosterol that belong to the class of tetracyclic steroids abundant in Rhoicissus tridentata ....

    Nondumiso Premilla Dube, Vuyelwa Jacqueline Tembu, ... Amanda-Lee Ezra Manicum in BMC Complementary Medicine and Therapies
    Article Open access 11 September 2023
  20. Evaluation of the effects of photodynamic therapy consisted of the blue laser and zinc oxide QDs on MDA-MB-231 cancer cells by inhibiting cancer markers and inducing apoptosis

    The increasing number of cancer patients has cast attention on develo** new anti-cancer modalities. Photodynamic therapy is a safe anti-cancer...

    Fatemeh Javani Jouni, Nima Rastegar-Pouyani, ... Jaber Zafari in Lasers in Medical Science
    Article 13 January 2024
Did you find what you were looking for? Share feedback.